Williams & Novak
LLY icon

Williams & Novak’s Eli Lilly LLY Stock Holding History

Williams & Novak’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$307K Sell
265
-158
-37% -$186K 0.18% 97
2026
Q2 		$507K Buy
+423
New +$432K 0.34% 71
2025
Q4 		– Sell
-509
Closed -$388K – 152
2025
Q3 		$388K Buy
509
+81
+19% +$60.3K 0.3% 75
2025
Q2 		$334K Buy
+428
New +$333K 0.28% 83

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Williams & Novak's LLY Position: Q3 2026 in Review

Williams & Novak reduced its Eli Lilly (LLY) stake by 37% in Q3 2026, selling an estimated $186K and leaving 265 shares worth $307K. The position accounts for 0.18% of the portfolio, ranked #97.

Williams & Novak first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $507K in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Williams & Novak held 265 shares of Eli Lilly worth $307K as of Q3 2026.
  • Williams & Novak sold 158 Eli Lilly shares in Q3 2026, an estimated $186K.
  • Eli Lilly made up 0.18% of Williams & Novak's portfolio in Q3 2026, its #97 holding.
  • Williams & Novak first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
  • Williams & Novak's Eli Lilly position peaked at $507K in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Williams & Novak's 13F filing for Q3 2026, filed 9 Oct 2026.